Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nep… Read more
Torrent Pharmaceuticals Limited (TORNTPHARM) - Total Assets
Latest total assets as of September 2025: ₹155.15 Billion INR
Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) holds total assets worth ₹155.15 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Torrent Pharmaceuticals Limited - Total Assets Trend (2005–2025)
This chart illustrates how Torrent Pharmaceuticals Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Torrent Pharmaceuticals Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Torrent Pharmaceuticals Limited's total assets of ₹155.15 Billion consist of 37.5% current assets and 62.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹2.32 Billion | 3.9% |
| Accounts Receivable | ₹18.67 Billion | 12.5% |
| Inventory | ₹25.41 Billion | 17.0% |
| Property, Plant & Equipment | ₹38.23 Billion | 25.5% |
| Intangible Assets | ₹42.63 Billion | 28.4% |
| Goodwill | ₹3.39 Billion | 2.3% |
Asset Composition Trend (2005–2025)
This chart illustrates how Torrent Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Torrent Pharmaceuticals Limited's current assets represent 37.5% of total assets in 2025, an increase from 37.3% in 2005.
- Cash Position: Cash and equivalents constituted 3.9% of total assets in 2025, up from 1.5% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 13.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 28.4% of total assets.
Torrent Pharmaceuticals Limited Competitors by Total Assets
Key competitors of Torrent Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
Torrent Pharmaceuticals Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Torrent Pharmaceuticals Limited generates 0.77x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Torrent Pharmaceuticals Limited generates $ 12.75 in net profit.
Torrent Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.39 | 1.21 | 1.17 |
| Quick Ratio | 0.84 | 0.74 | 0.65 |
| Cash Ratio | 0.16 | 0.24 | 0.00 |
| Working Capital | ₹17.36 Billion | ₹ 10.32 Billion | ₹ 8.41 Billion |
Torrent Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between Torrent Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.78 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -0.5% |
| Total Assets | ₹149.90 Billion |
| Market Capitalization | $5.27 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Torrent Pharmaceuticals Limited's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Torrent Pharmaceuticals Limited's assets decreased by 0.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Torrent Pharmaceuticals Limited (2005–2025)
The table below shows the annual total assets of Torrent Pharmaceuticals Limited from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹149.90 Billion | -0.47% |
| 2024-03-31 | ₹150.61 Billion | +0.32% |
| 2023-03-31 | ₹150.12 Billion | +14.60% |
| 2022-03-31 | ₹131.00 Billion | -6.93% |
| 2021-03-31 | ₹140.75 Billion | +0.26% |
| 2020-03-31 | ₹140.38 Billion | -0.59% |
| 2019-03-31 | ₹141.21 Billion | -0.86% |
| 2018-03-31 | ₹142.43 Billion | +40.67% |
| 2017-03-31 | ₹101.25 Billion | +12.33% |
| 2016-03-31 | ₹90.14 Billion | +13.94% |
| 2015-03-31 | ₹79.11 Billion | +56.04% |
| 2014-03-31 | ₹50.70 Billion | +34.02% |
| 2013-03-31 | ₹37.83 Billion | +23.08% |
| 2012-03-31 | ₹30.74 Billion | +20.61% |
| 2011-03-31 | ₹25.48 Billion | +29.68% |
| 2010-03-31 | ₹19.65 Billion | +17.85% |
| 2009-03-31 | ₹16.67 Billion | +31.73% |
| 2008-03-31 | ₹12.66 Billion | +21.14% |
| 2007-03-31 | ₹10.45 Billion | +10.94% |
| 2006-03-31 | ₹9.42 Billion | +32.54% |
| 2005-03-31 | ₹7.11 Billion | -- |